Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 281
Selected: 0
NCT IDTitle
NCT04514029Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00610740CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
NCT02370160HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma
NCT02988466Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT00478244Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
NCT06030648MT2022-01: MSCs for ALD
NCT00319748Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
NCT00383448HSCT for High Risk Inherited Inborn Errors
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT03019666Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
NCT00630565Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT00003926Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT00176839Stem Cell Transplantation for Hematological Malignancies
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT00357565Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT01288222Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT01601548Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT00346125PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT00331422Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00176930Stem Cell Transplant for Hematological Malignancy
NCT00903630Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT00265863Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
NCT02145039Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT00726739Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT02410239MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
NCT00005986Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia
NCT00345865Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT05025774Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT01181258Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
NCT00258427Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
NCT00281827Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
NCT01566682A Multi-Center Trial of the ProLung Test™
NCT00638820Reduced Intensity AlloTransplant For Osteopetrosis
NCT04858594Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
NCT00176891Stem Cell Transplant w/Laronidase for Hurler
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT00775931Allogeneic Transplantation For Severe Osteopetrosis